News & Announcements
A strong supporter of medical research, particularly within cancer, Jim Donovan of Goldman Sachs was nominated on March 14th.
The FNIH Biomarkers Consortium is launching a three-year research partnership to develop new methods for analyzing digital images, which will lead to new ways to track a patient’s response to cancer therapy.
New donation to the FNIH will support the research of W. Marston Linehan, M.D., at the National Cancer Institute, who is developing novel approaches to treat multiple forms of kidney cancer.
The FNIH President and Executive Director, Dr. Maria Freire, speaks about the transformative nature of biomedical research.
The Eliminate Dengue program is ramping up after discovering that the presence of Wolbachia bacteria in Aedes aegypti mosquitoes inhibits replication of the Zika virus.